Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment
- PMID: 19685283
- PMCID: PMC2756339
- DOI: 10.1007/s12307-009-0022-y
Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment
Abstract
Toll-like receptors (TLRs) play a crucial role in the innate immune response and the subsequent induction of adaptive immune responses against microbial infection or tissue injury. Recent findings show that functional TLRs are expressed not only on immune cells but also on cancer cells. TLRs play an active role in carcinogenesis and tumor progression during chronic inflammation that involves the tumor microenvironment. Damage-associated molecular patterns (DAMPs) derived from injured normal epithelial cells and necrotic cancer cells appear to be present at significant levels in the tumor microenvironment, and their stimulation of specific TLRs can foster chronic inflammation. This review discusses how carcinogenesis, cancer progression, and site-specific metastasis are related to interactions between cancer cells, immune cells, and DAMPs through TLR activation in the tumor microenvironment.
Figures
Similar articles
-
Toll-Like Receptors Signaling in the Tumor Microenvironment.Adv Exp Med Biol. 2020;1223:81-97. doi: 10.1007/978-3-030-35582-1_5. Adv Exp Med Biol. 2020. PMID: 32030686 Review.
-
Acute kidney injury: what part do toll-like receptors play?Int J Nephrol Renovasc Dis. 2014 Jun 19;7:241-51. doi: 10.2147/IJNRD.S37891. eCollection 2014. Int J Nephrol Renovasc Dis. 2014. PMID: 24971030 Free PMC article. Review.
-
The role of toll-like receptors (TLRs) in pan-cancer.Ann Med. 2022 Dec;54(1):1918-1937. doi: 10.1080/07853890.2022.2095664. Ann Med. 2022. PMID: 35801728 Free PMC article.
-
Toll-Like Receptors in Adaptive Immunity.Handb Exp Pharmacol. 2022;276:95-131. doi: 10.1007/164_2021_543. Handb Exp Pharmacol. 2022. PMID: 34510306
-
Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment.Pharmaceutics. 2022 Oct 25;14(11):2285. doi: 10.3390/pharmaceutics14112285. Pharmaceutics. 2022. PMID: 36365103 Free PMC article. Review.
Cited by
-
TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma.Oncol Lett. 2016 Jul;12(1):275-280. doi: 10.3892/ol.2016.4584. Epub 2016 May 16. Oncol Lett. 2016. PMID: 27347137 Free PMC article.
-
Single-cell RNA sequencing reveals the immune microenvironment landscape of osteosarcoma before and after chemotherapy.Heliyon. 2023 Dec 11;10(1):e23601. doi: 10.1016/j.heliyon.2023.e23601. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38332885 Free PMC article.
-
Functional annotation of melanoma risk loci identifies novel susceptibility genes.Carcinogenesis. 2020 Jun 17;41(4):452-457. doi: 10.1093/carcin/bgz173. Carcinogenesis. 2020. PMID: 31630191 Free PMC article.
-
Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets.Hemasphere. 2019 Jan 28;3(1):e168. doi: 10.1097/HS9.0000000000000168. eCollection 2019 Feb. Hemasphere. 2019. PMID: 31723807 Free PMC article. Review.
-
TLR4 Agonist and Hypoxia Synergistically Promote the Formation of TLR4/NF-κB/HIF-1α Loop in Human Epithelial Ovarian Cancer.Anal Cell Pathol (Amst). 2022 Apr 14;2022:4201262. doi: 10.1155/2022/4201262. eCollection 2022. Anal Cell Pathol (Amst). 2022. PMID: 35464826 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources